Automated Insulin Delivery

The AJMC® Automated Insulin Delivery compendium is a comprehensive resource for clinical news and expert insights for this technology, which has revolutionized diabetes care.

Latest News

AI graphic | Image Credit: © NicoElNino-stock.adobe.com

Enhancing Myasthenia Gravis Care With AI-Powered Telemedicine

By Kimberly Rath, PharmD

November 8th 2024

Researchers introduce a telemedicine system powered by artificial intelligence (AI) that automatically scores neuromuscular examinations, offering the potential to enhance patient monitoring, reduce variability in clinical trials, and improve access to care for neuromuscular disorders like myasthenia gravis.

top 5 automated insulin delivery content for 2022

Top 5 Most-Read Articles About Automated Insulin Delivery in 2022

December 20th 2022

Patient education

Primary Care Clinicians Can Embrace CGM Implementation With Support, Study Finds

By Pearl Steinzor

December 6th 2022

Doctor patient consult

Study Identifies Factors Associated With Hypoglycemia Unawareness, Improvement

By Jared Kaltwasser

November 27th 2022

Abstract image of children receiving better care

Study Supports Funding for CGM to Improve Pediatric T1D Outcomes in New Zealand

By Rose McNulty

November 23rd 2022

A Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets

Read this review and Q&A with trial investigators of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in child and adult participants with type 1 diabetes.

Image of clinical brief about a tubeless, on-body automated insulin delivery system with customizable glycemic targets in child and adult participants with type 1 diabetes

More News

Image of a continuous glucose monitor

April 30th 2022

Real-Time CGM Can Help Shape Patient Education, Glycemic Index Measures in T2D

Investigators from Malaysia utilized data from real-time continuous glucose monitoring (CGM) among study participants who were considered overweight or obese to evaluate their risk of type 2 diabetes (T2D) associated with a rice-based meal and its impact on postprandial hyperglycemia.

mage of diabetes management

April 27th 2022

CLS Use Proved Superior at Reducing Adverse Outcomes in T1D vs Control Therapies

This systematic review and meta-analysis used a literature search to gather data from long-term randomized controlled trials on the effectiveness of closed-loop insulin systems (CLS) among nonpregnant patients with type 1 diabetes (T1D).

Image of a scale

April 23rd 2022

Use of CSII Linked to Lower Rates of DEB Among Children With T1D

This new study investigated and compared the incidence of disordered eating behavior (DEB) among 2 cohorts of patients with type 1 diabetes (T1D) treated with continuous-subcutaneous insulin infusion (CSII) or a basal-bolus regimen.

Image of AI

April 19th 2022

Model Algorithm Demonstrates Effectiveness for T1D Control During Pregnancy

Investigators fashioned a zone-model predictive controller to evaluate adjustment of closed-loop glycemic control during pregnancy, as both glycemic control and insulin adjustment continually change throughout gestation.

Image of a fitbit-type like device

April 15th 2022

Experts Explore the Potential of Wearable Tech in T1D Management

This new literature review explored the potential to enhance management for type 1 diabetes (T1D) through the adoption of physiological parameters measured by wearable and sensor-enabled health-related technology.

Image of the word diabetes

April 12th 2022

Pediatric T1D Targets Improve Following Pump Initiation Protocol

Improvements in time spent in target range and glycated hemoglobin A1c were investigated among 34 children with type 1 diabetes (T1D) with a history of daily insulin use and no prior use of diabetes technology.

Image of a woman using a health care app

April 8th 2022

Multidisciplinary, Virtual Endocrinology Care Improves Outcomes in Diabetes

This new study evaluated the impact of a virtual endocrinology care program on time in range and outcomes among individuals with poorly controlled diabetes who are novice users of continuous glucose monitoring.

Image of words "Learn More"

April 5th 2022

Lack of Diabetes Tech Knowledge Seen in Focus Group Study

Why persons with type 1 diabetes and continuous insulin infusion fail to achieve optimal glycemic control was the subject of a recent focus group analysis conducted among 37 adult men and women.

Image of diabetes control supplies

April 2nd 2022

Algorithm Facilitates Optimal Glycemic Monitoring in New Comparative Study

Because type 1 diabetes can be very difficult to effectively manage in children and adolescents, these study investigators compared outcomes between a hybrid closed-loop algorithm add-on and usual care.

Image of female patient and physician

March 31st 2022

Knowledge Lacking on Link Between AID Needs, Menstrual Cycle in Women

This subanalysis of participant data from the OPEN project investigated relationships between glycemic levels and insulin requirements among women with type 1 diabetes and phases of their menstrual cycle.

Image of research results

March 26th 2022

Patients With T2D, CAP Require Greater Daytime Oversight

Data from continuous glucose monitors were used to measure glycemic variability among patients with type 2 diabetes (T2D) and community-acquired pneumonia (CAP) hospitalized in Denmark between February and June 2021.

Image of words related to diabetes

March 22nd 2022

Neutral Findings Predominate German Study of CGM Use

This new study from Germany evaluated the use of and satisfaction with continuous glucose monitors (CGMs) since health insurance companies in the country began reimbursement of the technology in 2016 for persons with insulin-dependent diabetes.

Image of health graphic

March 19th 2022

CGM, Telemedicine Likely Buttressed Pediatric T1D Care During the Pandemic

This new investigation compared outcomes among pediatric patients with type 1 diabetes (T1D) before and after COVID-19 restrictions were imposed in Dallas County on March 15, 2020.

diabetes text

March 17th 2022

Case Series Highlights Lack of Equity in T1D Care

This new investigation evaluated outcomes among 6 youths with type 1 diabetes, who had public insurance coverage and received continuous glucose monitoring assistance through the CGM Time in Range Program.

Image of medical education

March 12th 2022

Study Reveals Limited HCP Knowledge May Hinder Use of Open-Source AID Tech

This new investigation from the United Kingdom evaluated health care professionals’ (HCP) perceptions and implementation of practices that focus on open-source automated insulin delivery (OS-AID).

Image of diabetes text highlighted

March 10th 2022

Closed-Loop Insulin Delivery May Facilitate Better Metabolic Control vs Pump

This new study of pediatric patients with type 1 diabetes from France and Belgium investigated the effectiveness of insulin delivery via closed-loop and open-loop systems.

Tubeless, On-Body Automated Insulin Delivery System Shows Benefits for Glucose Control

December 16th 2021

Tubeless, On-Body Automated Insulin Delivery System Shows Benefits for Glucose Control

Jaime Rosenberg

The insulin delivery system was linked with a reduction in hypoglycemia among adults and a decrease in hyperglycemia in both adults and children.

Uptake of Artificial Pancreas Systems in Primary Care Could Reduce Care Disparities

December 11th 2021

Uptake of Artificial Pancreas Systems in Primary Care Could Reduce Care Disparities

Jaime Rosenberg

Findings about the willingness of primary care providers to prescribe artificial pancreas systems have positive implications for increasing access to and reducing disparities around this technology by alleviating the need to see a specialist.

Fully Artificial Pancreas Falls Short of Achieving Noninferiority to Hybrid System, but Shows Promise

December 9th 2021

Fully Artificial Pancreas Falls Short of Achieving Noninferiority to Hybrid System, but Shows Promise

Jaime Rosenberg

The findings, said the researchers, are an important step toward achieving glucose control with a fully automated closed-loop system for patients with type 1 diabetes.

Exploring the Barriers to Uptake of Automated Insulin Delivery

December 4th 2021

Exploring the Barriers to Uptake of Automated Insulin Delivery

Authors from the University of Colorado say factors from skin irritations, to cost, to lack of insurance coverage, to physician barriers have limited uptake of automated insulin delivery systems.

doctors consulting

December 1st 2021

New Guidelines Offer Advice for Clinicians as Open-Source Automated Insulin Grows in Popularity

Jared Kaltwasser

Clinicians should be willing to work with patients eager to try “do-it-yourself” insulin systems, but should also warn them of the risks, the guidelines state.

blood sugar graphic

November 27th 2021

Study Finds Fully Closed-Loop Insulin System Outperforms Standard Insulin Therapy in T2D

Jared Kaltwasser

An open-label randomized trial found patients using the closed-loop system had more time in their target glucose ranges.

Closed-Loop Insulin System Is Cost-effective in Type 1 Diabetes, Analysis Says

November 15th 2021

Closed-Loop Insulin System Is Cost-effective in Type 1 Diabetes, Analysis Says

Jared Kaltwasser

Lower indirect costs and a lower incidence of serious complications offset the higher cost of the advanced hybrid closed-loop insulin system.

November 12th 2021

Flash CGM Associated With Event Reduction in Nonintensive Diabetes Therapy

Eden Miller, DO Matthew S. D. Kerr, PhD Gregory J. Roberts, BS Yelena Nabutovsky, MS Eugene Wright, MD

Analysis of the MarketScan database showed a strong association between flash continuous glucose monitoring (CGM) use and significant reductions in diabetes-related events and hospitalizations in a cohort of 10,282 adults with type 2 diabetes.

COVID-19 Led to Overall Drop in Prescribing of Insulin to Adults, Study Finds

November 11th 2021

COVID-19 Led to Overall Drop in Prescribing of Insulin to Adults, Study Finds

Although the authors say their findings shed light on possible disruptions to insulin supply during COVID-19, they note they could not adjust for those with diabetes who died.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions